Opko Health Inc (OPK)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.25B
Last updated: Nov 17, 2026 at 11:06 AM ET
Opko Health Inc (OPK) Competitors
The companies most similar to Opko Health are NeoGenomics (NEO), Personalis (PSNL) and Castle Biosciences (CSTL). By market cap, Opko Health ranks 9th of the 13 companies on this page; ICON (ICLR) is the largest at $14.58B. The median P/E of the 5 companies with a P/E is 20.0x.
Peer Comparison
OPK's ROIC of -6.2% is below the peer median of 2.8%, and its revenue growth of 15.9% is above the median of 9.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Opko Health (OPK) | $1.25B | N/A | 2.4x | -22.6% | -6.2% | 15.9% | 0.00% |
| NeoGenomics Inc (NEO) | $2.07B | 228.9x | 2.6x | -4.1% | -2.5% | 11.4% | 0.00% |
| Personalis Inc (PSNL) | $1.70B | N/A | 20.9x | -147.7% | N/A | 76.6% | 0.00% |
| Castle Biosciences Inc (CSTL) | $1.04B | N/A | 2.7x | -6.1% | -5.4% | 23.9% | 0.00% |
| Veracyte Inc (VCYT) | $1.96B | 13.3x | 3.3x | 21.8% | 8.2% | 15.1% | 0.00% |
| Fulgent Genetics Inc (FLGT) | $688.98M | N/A | 2.0x | -27.5% | -12.1% | 7.5% | 0.00% |
| Myriad Genetics Inc (MYGN) | $542.92M | N/A | 0.7x | -16.1% | -29.5% | -1.5% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Sotera Health Co (SHC) | $4.74B | 17.1x | 3.8x | 14.1% | 9.0% | 4.4% | 0.00% |
| Adaptive Biotechnologies Corp (ADPT) | $4.70B | N/A | 15.0x | -23.7% | N/A | -10.7% | 0.00% |
| Omeros Corporation (OMER) | $1.27B | N/A | 16.4x | 324.9% | 33.6% | 14.9% | 0.00% |
| ICON PLC (ICLR) | $14.58B | 20.0x | 1.8x | 5.3% | 2.8% | -2.9% | 0.00% |
| Insight Molecular Diagnostics Inc. (IMDX) | $70.03M | N/A | 40.9x | 0.0% | 197.8% | -53.9% | 0.00% |
| Peer median | $1.83B | 20.0x | 3.6x | -2.0% | 2.8% | 9.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Opko Health, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Diagnostics & Research; the other one is in Biotechnology.
| Company | About | Peers |
|---|---|---|
| NeoGenomics Inc (NEO)Diagnostics & Research | NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. | NEO competitors |
| Personalis Inc (PSNL)Diagnostics & Research | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. | PSNL competitors |
| Castle Biosciences Inc (CSTL)Diagnostics & Research | Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests... | CSTL competitors |
| Veracyte Inc (VCYT)Diagnostics & Research | Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California. | VCYT competitors |
| Fulgent Genetics Inc (FLGT)Diagnostics & Research | Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. | FLGT competitors |
| Myriad Genetics Inc (MYGN)Diagnostics & Research | Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized... | MYGN competitors |
| CareDx Inc (CDNA)Diagnostics & Research | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
| Sotera Health Co (SHC)Diagnostics & Research | Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical... | SHC competitors |
| Adaptive Biotechnologies Corp (ADPT)Diagnostics & Research | Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. | ADPT competitors |
| Omeros Corporation (OMER)Biotechnology | Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies... | OMER competitors |
| ICON PLC (ICLR)Diagnostics & Research | ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe... | ICLR competitors |
| Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research | OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California. | IMDX competitors |
Frequently Asked Questions About OPK
Who are Opko Health's main competitors?
The companies most similar to Opko Health include NeoGenomics (NEO), Personalis (PSNL), Castle Biosciences (CSTL), Veracyte (VCYT) and Fulgent Genetics (FLGT), listed from the closest match.
Who is Opko Health's biggest competitor?
ICON (ICLR) is the largest of the similar companies at $14.58B; NeoGenomics (NEO) is the closest match by business profile, size, sector and industry.
How does OPK stock compare with its competitors?
OPK's P/S is 2.4x against a peer median of 3.6x; its net margin is -22.6% against a peer median of -2.0%.
Which of Opko Health's competitors pays a higher dividend?
Opko Health pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Opko Health bigger than its competitors?
No. Opko Health is 9th by market cap among the 13 companies on this page; the largest is ICON (ICLR) at $14.58B.
OPK pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts